Literature DB >> 6430643

Phenoxybenzamine--an effective male contraceptive pill.

Z T Homonnai, M Shilon, G F Paz.   

Abstract

Phenoxybenzamine (PBZ), administered in doses up to 20 mg/day, caused aspermia following male orgasm. This led to the development of a male contraceptive pill, PBZ being the active drug. It has been shown that small doses of the drug do not change the hormonal balance of the body, nor do they affect blood pressure. In 2 to 3 days, PBZ blocks ejaculation; this is fully reversed with the cessation of treatment. The drug does not affect semen quality (testicular function), even after a long period of medication. During treatment, the vas deferens, the ampulla and the ejaculatory ducts are probably paralyzed. Cessation of medication brought full recovery of these effects and the reappearance of normal ejaculation. Men complaining of premature ejaculation reported marked improvement in their sexual performance. The recommended regimen for administering PBZ as a male contraceptive is discussed.

Entities:  

Keywords:  Androgens; Biology; Blood Pressure; Contraception; Contraception Research; Evaluation; Family Planning; Follicle Stimulating Hormone; Genitalia; Genitalia, Male; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone; Male Contraception; Physiology; Prolactin; Semen--analysis; Seminal Vesicles; Urogenital System

Mesh:

Substances:

Year:  1984        PMID: 6430643     DOI: 10.1016/0010-7824(84)90022-2

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

1.  Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice.

Authors:  Carl W White; Yan-Ting Choong; Jennifer L Short; Betty Exintaris; Daniel T Malone; Andrew M Allen; Richard J Evans; Sabatino Ventura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

2.  A prospective double-blind, randomized, placebo-controlled study to evaluate the efficacy of silodosin 8 mg as an on-demand, reversible, nonhormonal oral contraceptive for males: a pilot study.

Authors:  Gajanan S Bhat; Anuradha Shastry
Journal:  World J Urol       Date:  2019-05-10       Impact factor: 4.226

Review 3.  Current and emerging treatment options for premature ejaculation.

Authors:  Murat Gul; Kadir Bocu; Ege Can Serefoglu
Journal:  Nat Rev Urol       Date:  2022-08-25       Impact factor: 16.430

4.  Antifertility activity of Cryptolepis sanguinolenta leaf ethanolic extract in male rats.

Authors:  Ayodeji F Ajayi; Roland E Akhigbe
Journal:  J Hum Reprod Sci       Date:  2012-01

Review 5.  The future of male contraception: a fertile ground.

Authors:  Iyad Khourdaji; Jacqueline Zillioux; Kevin Eisenfrats; Daniel Foley; Ryan Smith
Journal:  Transl Androl Urol       Date:  2018-05

Review 6.  Hypertension and Male Fertility.

Authors:  David Guo; Shufeng Li; Barry Behr; Michael L Eisenberg
Journal:  World J Mens Health       Date:  2017-08       Impact factor: 5.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.